AI CuratorAI-generated
Research summary · AI summary · not yet reviewedSubjects not reportedNot reportedTrial registry
Adaptation and Validation of the USE-MS Scale in Turkish (No Animal/Cell Subjects)
A study was conducted with 176 participants aiming to adapt the Unidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS) into Turkish, focusing on its validity and reliability.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
This adaptation is important as it seeks to provide Turkish-speaking individuals with a validated tool to assess self-efficacy in managing multiple sclerosis, potentially enhancing research and clinical communication.
What this does not prove
The source does not report results or efficacy, and there are no findings regarding planned enrollment or endpoints.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- 176 · basis not reported
- Randomised
- No
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- No
- Research areas
- Not classified
Original sources
Supporting passages (7)
sample size176
randomizedNo
regulatory approvalNo
interventionValidity, Reliability and Adaptation
primary endpointUnidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS)
findingsThe aim of this study is to adapt the \"USE-MS\" scale into Turkish and to establish its validity and reliability.
limitationsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.